Johannesson, M <br/><br/>
The cost-effectiveness of the switch towards more expensive antihypertensive drugs.  [electronic resource] 

 -  Health policy (Amsterdam, Netherlands)  Mar 1994 
 - 1-13 p.  digital 
<br/><br/> Publication Type: Comparative Study; Journal Article; Research Support, Non-U.S. Gov't; Review 
<br/><br/><label>ISSN: </label>0168-8510 
<br/><br/><label>Standard No.: </label>10.1016/0168-8510(94)90016-7  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adrenergic beta-Antagonists--economics<br/>Antihypertensive Agents--economics<br/>Calcium Channel Blockers--economics<br/>Cost-Benefit Analysis--statistics & numerical data<br/>Data Collection<br/>Drug Costs--statistics & numerical data<br/>Humans<br/>Hypertension--drug therapy<br/>Quality of Life<br/>Risk Factors<br/>Sweden--epidemiology<br/>Value of Life